首页 > 最新文献

Acta Facultatis Medicae Naissensis最新文献

英文 中文
The risk of falls in patients with cerebrovascular disease 脑血管疾病患者跌倒的危险
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.5937/afmnai40-41745
Aleksandar Nenadović, Olivera Đurović, Snezana Stanković, Biljana Georgievski-Brkić, Milica Milivojević, Marjana Vukičević, Svetlana Radević, Snežana Radovanović
Introduction/Aim. Patient falls in hospital conditions are among the most common serious adverse events following a cerebrovascular insult at all stages of the disease. The aim of this study was to investigate the risk of falls in patients with cerebrovascular disease. Methods. A clinical case-control observational study was conducted in this investigation. The sample consisted of patients who suffered from cerebrovascular diseases and were admitted to the Special Hospital for Cerebrovascular Diseases "Sveti Sava" in Belgrade, in the period from February 3, 2018, to June 28, 2019. The Morse questionnaire was used to assess a fall risk. All statistical calculations were performed using the standard commercial software package SPSS, version 21.0. Results. Most of the subjects with a cerebrovascular insult (505 (90.0%)) had a high risk of falls, i.e. they had the Morse score values ≥ 45. The mean Morse score of the subjects in the study was 67.07 ± 21.08. The risk of falling, according to the Morse score, is the highest among subjects diagnosed with bleeding (95.7%: 96.7%) and left-sided neurological deficit (91.7%:90.8%) in both examined groups. Conclusion. It is of great importance to organizing training programs for patients, healthcare providers, and medical staff to prevent falls in hospital conditions.
介绍/目标。患者在住院条件下跌倒是在疾病的所有阶段脑血管损伤后最常见的严重不良事件之一。本研究的目的是调查脑血管疾病患者跌倒的风险。方法。本研究采用临床病例对照观察性研究。样本由2018年2月3日至2019年6月28日期间在贝尔格莱德脑血管疾病“Sveti Sava”专科医院住院的脑血管疾病患者组成。莫尔斯问卷用于评估跌倒风险。所有统计计算均使用标准商业软件包SPSS 21.0进行。结果。大多数脑血管损伤患者(505例(90.0%))有较高的跌倒风险,即莫尔斯评分≥45。研究对象的莫尔斯平均分为67.07±21.08。根据莫尔斯评分,在两组被诊断为出血(95.7%:96.7%)和左侧神经功能障碍(91.7%:90.8%)的受试者中跌倒的风险最高。结论。为患者、医疗保健提供者和医务人员组织培训计划以防止在医院条件下跌倒是非常重要的。
{"title":"The risk of falls in patients with cerebrovascular disease","authors":"Aleksandar Nenadović, Olivera Đurović, Snezana Stanković, Biljana Georgievski-Brkić, Milica Milivojević, Marjana Vukičević, Svetlana Radević, Snežana Radovanović","doi":"10.5937/afmnai40-41745","DOIUrl":"https://doi.org/10.5937/afmnai40-41745","url":null,"abstract":"Introduction/Aim. Patient falls in hospital conditions are among the most common serious adverse events following a cerebrovascular insult at all stages of the disease. The aim of this study was to investigate the risk of falls in patients with cerebrovascular disease. Methods. A clinical case-control observational study was conducted in this investigation. The sample consisted of patients who suffered from cerebrovascular diseases and were admitted to the Special Hospital for Cerebrovascular Diseases \"Sveti Sava\" in Belgrade, in the period from February 3, 2018, to June 28, 2019. The Morse questionnaire was used to assess a fall risk. All statistical calculations were performed using the standard commercial software package SPSS, version 21.0. Results. Most of the subjects with a cerebrovascular insult (505 (90.0%)) had a high risk of falls, i.e. they had the Morse score values ≥ 45. The mean Morse score of the subjects in the study was 67.07 ± 21.08. The risk of falling, according to the Morse score, is the highest among subjects diagnosed with bleeding (95.7%: 96.7%) and left-sided neurological deficit (91.7%:90.8%) in both examined groups. Conclusion. It is of great importance to organizing training programs for patients, healthcare providers, and medical staff to prevent falls in hospital conditions.","PeriodicalId":7132,"journal":{"name":"Acta Facultatis Medicae Naissensis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135612329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MicroRNA: Potential biomarkers in chronic kidney disease MicroRNA:慢性肾脏疾病的潜在生物标志物
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.5937/afmnai40-39805
Vladana Stojiljković, Nikola Stefanović, Marija Vukelić-Nikolić, Branka Đorđević, Jelena Bašić, Gordana Kocić, Tatjana Cvetković
Introduction. Standard biomarkers for the diagnosis and follow-up of chronic kidney disease patients are appropriate neither in early diagnostics, adequate follow-up and progression assessment nor in complication development risk assessment. For that reason, a search for new, more suitable biomarkers continues. Various studies suggested microRNAs as a potential solution, as they are involved in the pathogenesis of diabetic nephropathy, kidney cancer and kidney function impairment in general. Methods. Internet search engines were used to find and select relevant literature data and electronic databases. Results. Research published so far, in oncology especially, have reported various single microRNAs and panels of microRNAs as candidates for routine diagnostic implementation. Chronic kidney disease is, however, quite complex in terms of etiology of the disease occurrence, since there are many causes that can lead to kidney tissue damage and impairment of its function and finally full development of the chronic kidney disease. MicroRNAs are stable in bodily fluids, and hemodialysis procedure does not affect their levels. Also, high RNase activity in chronic kidney disease patients does not accelerate microRNA degradation in their samples. Conclusions. Literature data suggest that microRNAs are appropriate candidates for diagnostic use in chronic kidney disease. However, there are challenges that are yet to be overcome in order to use microRNAs routinely.
介绍。慢性肾病患者诊断和随访的标准生物标志物既不适用于早期诊断、充分的随访和进展评估,也不适用于并发症发展风险评估。因此,寻找新的、更合适的生物标志物的工作仍在继续。各种研究表明,microRNAs是一种潜在的解决方案,因为它们通常与糖尿病肾病、肾癌和肾功能损害的发病机制有关。方法。利用网络搜索引擎查找和选择相关文献资料和电子数据库。结果。迄今为止发表的研究,特别是在肿瘤学方面,已经报道了各种单一microrna和microrna组作为常规诊断实施的候选物。然而,慢性肾脏疾病发生的病因是相当复杂的,因为有很多原因可以导致肾脏组织损伤和功能损害,最终导致慢性肾脏疾病的全面发展。微rna在体液中是稳定的,血液透析过程不会影响它们的水平。此外,慢性肾病患者的高RNase活性不会加速其样品中的microRNA降解。结论。文献资料表明,microrna是诊断慢性肾脏疾病的合适候选者。然而,为了常规使用microrna,还有一些挑战有待克服。
{"title":"MicroRNA: Potential biomarkers in chronic kidney disease","authors":"Vladana Stojiljković, Nikola Stefanović, Marija Vukelić-Nikolić, Branka Đorđević, Jelena Bašić, Gordana Kocić, Tatjana Cvetković","doi":"10.5937/afmnai40-39805","DOIUrl":"https://doi.org/10.5937/afmnai40-39805","url":null,"abstract":"Introduction. Standard biomarkers for the diagnosis and follow-up of chronic kidney disease patients are appropriate neither in early diagnostics, adequate follow-up and progression assessment nor in complication development risk assessment. For that reason, a search for new, more suitable biomarkers continues. Various studies suggested microRNAs as a potential solution, as they are involved in the pathogenesis of diabetic nephropathy, kidney cancer and kidney function impairment in general. Methods. Internet search engines were used to find and select relevant literature data and electronic databases. Results. Research published so far, in oncology especially, have reported various single microRNAs and panels of microRNAs as candidates for routine diagnostic implementation. Chronic kidney disease is, however, quite complex in terms of etiology of the disease occurrence, since there are many causes that can lead to kidney tissue damage and impairment of its function and finally full development of the chronic kidney disease. MicroRNAs are stable in bodily fluids, and hemodialysis procedure does not affect their levels. Also, high RNase activity in chronic kidney disease patients does not accelerate microRNA degradation in their samples. Conclusions. Literature data suggest that microRNAs are appropriate candidates for diagnostic use in chronic kidney disease. However, there are challenges that are yet to be overcome in order to use microRNAs routinely.","PeriodicalId":7132,"journal":{"name":"Acta Facultatis Medicae Naissensis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135610800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of the disease duration and administered therapy with metabolic syndrome in patients with systemic lupus erythematosus 系统性红斑狼疮患者代谢综合征的疾病持续时间和给药治疗的相关性
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.5937/afmnai40-40813
Jovana Cvetković, Sonja Stojanović, Ivan Tasić, Bojana Stamenković, Jovan Nedović, Sanja Stojanović
Aim. The aim of the paper was to examine the impact of disease duration and administered therapy on the development of metabolic syndrome (MetS) in patients with systemic lupus erythematosus (SLE). Material and methods. This study involved 55 patients (50 females and 5 males) with the diagnosis and 49 healthy controls of similar age. MetS was defined according to modified NCEP-ATP III diagnostic criteria, and obesity was defined by body mass index BMI > 30. Results. In the group of SLE patients with MetS, there were 23 individuals (41.82%). In the control group, there were 10 (20.4%) patients with MetS. There were significantly more SLE patients with MetS in comparison to the controls (p = 0.04). Duration of the disease in the group with MetS was longer in comparison to those without MetS, but it was not statistically significant (15.35 ± 10.26 vs 10.44 ± 7.88, p = 0.073). The study confirmed that there is a moderate association (CC = 0.355) between disease duration and number of MetS parameters, however, this dependency was not statistically significant (p = 0.439). In the group without MetS, there were statistically more patients treated with antimalarial drugs monotherapy (p = 0.023). It has been found that the patients with MetS were treated with corticosteroid therapy longer than those without MetS, but it was not statistically significant (153.57 ± 103.34 vs 114.75 ± 83.32, p = 0.129). Conclusion. Patients with longer SLE duration have more often MetS. It has been shown that, statistically, more patients without MetS were treated with antimalarial drugs monotherapy, and that long-term CS use, in our study, was not associated with higher incidence of MetS.
的目标。本文的目的是研究疾病持续时间和给药治疗对系统性红斑狼疮(SLE)患者代谢综合征(MetS)发展的影响。材料和方法。本研究纳入55例确诊患者(50例女性,5例男性)和49例年龄相仿的健康对照。根据修改后的NCEP-ATP III诊断标准定义MetS,根据体重指数BMI >定义肥胖;30.结果。合并MetS的SLE患者组有23例(41.82%)。在对照组中,有10例(20.4%)患者发生MetS。与对照组相比,合并met的SLE患者明显更多(p = 0.04)。有MetS组病程较无MetS组长,但差异无统计学意义(15.35±10.26 vs 10.44±7.88,p = 0.073)。研究证实,病程与MetS参数数量之间存在中度相关性(CC = 0.355),但这种相关性无统计学意义(p = 0.439)。在没有MetS的组中,使用抗疟药物单一治疗的患者有统计学意义(p = 0.023)。研究发现,有MetS的患者比无MetS的患者接受皮质类固醇治疗的时间更长,但差异无统计学意义(153.57±103.34 vs 114.75±83.32,p = 0.129)。结论。SLE病程较长的患者有较多的MetS。从统计上看,更多未患MetS的患者接受抗疟药物单药治疗,而在我们的研究中,长期使用抗疟药物与较高的MetS发生率无关。
{"title":"Association of the disease duration and administered therapy with metabolic syndrome in patients with systemic lupus erythematosus","authors":"Jovana Cvetković, Sonja Stojanović, Ivan Tasić, Bojana Stamenković, Jovan Nedović, Sanja Stojanović","doi":"10.5937/afmnai40-40813","DOIUrl":"https://doi.org/10.5937/afmnai40-40813","url":null,"abstract":"Aim. The aim of the paper was to examine the impact of disease duration and administered therapy on the development of metabolic syndrome (MetS) in patients with systemic lupus erythematosus (SLE). Material and methods. This study involved 55 patients (50 females and 5 males) with the diagnosis and 49 healthy controls of similar age. MetS was defined according to modified NCEP-ATP III diagnostic criteria, and obesity was defined by body mass index BMI > 30. Results. In the group of SLE patients with MetS, there were 23 individuals (41.82%). In the control group, there were 10 (20.4%) patients with MetS. There were significantly more SLE patients with MetS in comparison to the controls (p = 0.04). Duration of the disease in the group with MetS was longer in comparison to those without MetS, but it was not statistically significant (15.35 ± 10.26 vs 10.44 ± 7.88, p = 0.073). The study confirmed that there is a moderate association (CC = 0.355) between disease duration and number of MetS parameters, however, this dependency was not statistically significant (p = 0.439). In the group without MetS, there were statistically more patients treated with antimalarial drugs monotherapy (p = 0.023). It has been found that the patients with MetS were treated with corticosteroid therapy longer than those without MetS, but it was not statistically significant (153.57 ± 103.34 vs 114.75 ± 83.32, p = 0.129). Conclusion. Patients with longer SLE duration have more often MetS. It has been shown that, statistically, more patients without MetS were treated with antimalarial drugs monotherapy, and that long-term CS use, in our study, was not associated with higher incidence of MetS.","PeriodicalId":7132,"journal":{"name":"Acta Facultatis Medicae Naissensis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135611039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of ELOVL3 as a novel prognostic marker for liver cancer ELOVL3作为新的肝癌预后标志物的鉴定
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.5937/afmnai40-40853
Yiyang Chen, Wanbang Zhou, Yiju Gon, Xi Ou
Introduction. The incidence of liver cancer is increasing globally. Fatty acids in lipid metabolism are associated with cancer risk by maintaining cancer cell membrane structure and transducing cancer signaling, and their increased synthesis promotes tumor growth, angiogenesis, and tumor metastasis. Methods. After identification of the ELOVL3 gene involved in fatty acid metabolism, which is related to the prognosis of liver cancer, its expression level was extracted from The Cancer Genome Atlas (TCGA) database, and differential analysis, survival analysis, clinical correlation analysis and nomogram were used to predict the survival rate. A comprehensive meta-analysis was performed to further evaluate the prognostic value of ELOVL3. Finally, enrichment analysis and immune analysis were performed on the high and low expression groups of ELOVL3 gene to explore the value of ELOVL3 in predicting the prognosis and immunotherapy of liver cancer patients. Results. Patients with high ELOVL3 expression had poor overall survival and progression-free survival. The nomogram and the area under the ROC curve also indicated that the expression of ELOVL3 gene had high accuracy in predicting the survival time of liver cancer patients. The expression of ELOVL3 was significantly different in the early stage of tumor grade, tumor stage and T stage. Enrichment analysis and immunological analysis revealed a variety of information. The immunotherapy analysis also showed that low ELOVL3 was more effective than high ELOVL3 when receiving immunotherapy. Conclusion. The expression of ELOVL3 gene is significantly elevated in HCC and is associated with cancer development and poor prognosis.
介绍。肝癌的发病率在全球范围内呈上升趋势。脂质代谢中的脂肪酸通过维持肿瘤细胞膜结构和传导癌症信号与癌症风险相关,其合成增加促进肿瘤生长、血管生成和肿瘤转移。方法。在鉴定出与肝癌预后相关的参与脂肪酸代谢的ELOVL3基因后,从the cancer Genome Atlas (TCGA)数据库中提取其表达水平,采用差异分析、生存分析、临床相关分析和nomogram预测生存率。采用综合meta分析进一步评价ELOVL3的预后价值。最后对ELOVL3基因高表达组和低表达组进行富集分析和免疫分析,探讨ELOVL3基因在预测肝癌患者预后和免疫治疗中的价值。结果。ELOVL3高表达的患者总生存期和无进展生存期较差。nomogram和ROC曲线下面积也显示ELOVL3基因的表达对肝癌患者生存时间的预测具有较高的准确性。ELOVL3的表达在肿瘤分级、肿瘤分期和T期的早期有显著差异。富集分析和免疫学分析揭示了多种信息。免疫治疗分析也显示,在接受免疫治疗时,低ELOVL3比高ELOVL3更有效。结论。ELOVL3基因在HCC中的表达显著升高,与肿瘤发展和不良预后相关。
{"title":"Identification of ELOVL3 as a novel prognostic marker for liver cancer","authors":"Yiyang Chen, Wanbang Zhou, Yiju Gon, Xi Ou","doi":"10.5937/afmnai40-40853","DOIUrl":"https://doi.org/10.5937/afmnai40-40853","url":null,"abstract":"Introduction. The incidence of liver cancer is increasing globally. Fatty acids in lipid metabolism are associated with cancer risk by maintaining cancer cell membrane structure and transducing cancer signaling, and their increased synthesis promotes tumor growth, angiogenesis, and tumor metastasis. Methods. After identification of the ELOVL3 gene involved in fatty acid metabolism, which is related to the prognosis of liver cancer, its expression level was extracted from The Cancer Genome Atlas (TCGA) database, and differential analysis, survival analysis, clinical correlation analysis and nomogram were used to predict the survival rate. A comprehensive meta-analysis was performed to further evaluate the prognostic value of ELOVL3. Finally, enrichment analysis and immune analysis were performed on the high and low expression groups of ELOVL3 gene to explore the value of ELOVL3 in predicting the prognosis and immunotherapy of liver cancer patients. Results. Patients with high ELOVL3 expression had poor overall survival and progression-free survival. The nomogram and the area under the ROC curve also indicated that the expression of ELOVL3 gene had high accuracy in predicting the survival time of liver cancer patients. The expression of ELOVL3 was significantly different in the early stage of tumor grade, tumor stage and T stage. Enrichment analysis and immunological analysis revealed a variety of information. The immunotherapy analysis also showed that low ELOVL3 was more effective than high ELOVL3 when receiving immunotherapy. Conclusion. The expression of ELOVL3 gene is significantly elevated in HCC and is associated with cancer development and poor prognosis.","PeriodicalId":7132,"journal":{"name":"Acta Facultatis Medicae Naissensis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135611042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Necrotizing fascitis: A case report 坏死性筋膜炎1例
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.5937/afmnai40-39840
Mladen Kasalović, Gojko Igrutinović, Zlatan Elek, Aleksandar Jakovljević, Nikola Miljković, Milica Milentijević
Background. Necrotizing soft tissue infections are actually the diseases with a severe outcome characterized by the progression of soft tissue inflammation with a catastrophic prognosis and the risk of major functional consequences. Only prompt diagnosis and prompt care, including prompt administration of appropriate antibiotic therapy and surgical treatment, can improve the outcome. Case report. A female patient, aged 66 years, came due to swelling and pain in the perineum. Before admission, the pains were of low intensity, and immediately before admission, their intensity increased. An incision was made in the perineal region and the abdominal region on the left. During the preparation, we came across a necrotic tissue from which a dark-gray liquid flew that had a strong smell. From the tenth postoperative day, secondary sutures were partly placed. Conclusion. Mortality and morbidity in this disease are high. A potential new treatment for this disease may be an antigen-inhibiting vaccine.
背景。坏死性软组织感染是一种具有严重后果的疾病,其特征是软组织炎症的进展,具有灾难性的预后和主要功能后果的风险。只有及时诊断和及时护理,包括及时给予适当的抗生素治疗和手术治疗,才能改善预后。病例报告。女患者,66岁,因会阴肿痛就诊。入院前疼痛强度低,入院前疼痛强度增高。左侧会阴区和腹部各开一个切口。在准备过程中,我们发现了一个坏死的组织,其中有一种深灰色的液体,有一种强烈的气味。从术后第10天开始,部分进行二次缝合。结论。这种疾病的死亡率和发病率都很高。一种潜在的治疗这种疾病的新方法可能是抗原抑制疫苗。
{"title":"Necrotizing fascitis: A case report","authors":"Mladen Kasalović, Gojko Igrutinović, Zlatan Elek, Aleksandar Jakovljević, Nikola Miljković, Milica Milentijević","doi":"10.5937/afmnai40-39840","DOIUrl":"https://doi.org/10.5937/afmnai40-39840","url":null,"abstract":"Background. Necrotizing soft tissue infections are actually the diseases with a severe outcome characterized by the progression of soft tissue inflammation with a catastrophic prognosis and the risk of major functional consequences. Only prompt diagnosis and prompt care, including prompt administration of appropriate antibiotic therapy and surgical treatment, can improve the outcome. Case report. A female patient, aged 66 years, came due to swelling and pain in the perineum. Before admission, the pains were of low intensity, and immediately before admission, their intensity increased. An incision was made in the perineal region and the abdominal region on the left. During the preparation, we came across a necrotic tissue from which a dark-gray liquid flew that had a strong smell. From the tenth postoperative day, secondary sutures were partly placed. Conclusion. Mortality and morbidity in this disease are high. A potential new treatment for this disease may be an antigen-inhibiting vaccine.","PeriodicalId":7132,"journal":{"name":"Acta Facultatis Medicae Naissensis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135612315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Right ventricular metastasis of uterine cervical cancer: A case report 子宫颈癌右心室转移1例
Q4 Medicine Pub Date : 2023-01-01 DOI: 10.5937/afmnai40-39597
Milovan Stojanović, Bojan Ilić, Dragan Marinković, Sandra Šarić, Dejan Hristov, Marina Deljanin-Ilić
Introduction. Cardiac metastasis of uterine cervical cancer diagnosed prior to mortality (antemortem) is extremely rare. Case report. A female patient 49 years old was brought to the Emergency Department of the Institute for Treatment and Rehabilitation Niška Banja in cardiac arrest, without a pulse and blood pressure. An electrocardiogram revealed sustained ventricular tachycardia, which was terminated by two DC shocks (100J + 150J). Anamnesis and medical history revealed that she had had her squamous cell carcinoma of the uterine cervix removed and had subsequently received seven out of ten planned cycles of chemotherapy and twenty-eight cycles of radiotherapy. The patient was then transferred to the Coronary Unit, where cardiac ultrasound was performed. A homogenous mass measuring 31 x 50 mm was found in the right ventricle. In view of this, cardiac magnetic resonance imaging was performed. This confirmed the presence of the tumor mass in the right ventricle. Unfortunately, only a month after being discharged from our Institute, the patient was admitted to the Clinic of Neurology due to a loss of consciousness. Computer tomography of endocranium was performed revealing metastatic brain lesions. The patient succumbed to the disease just a couple of months later. Conclusion. We presented a rare case of antemortem diagnosed right ventricle metastases in a patient with uterine cervical cancer. Setting the diagnosis in these patients is a challenge in everyday clinical practice since metastases can produce the clinical picture that masks the real etymology of uterine cervical cancer.
介绍。子宫癌心脏转移在死亡前(死前)诊断是极为罕见的。病例报告。一名49岁的女病人被送到治疗和康复研究所Niška Banja急诊科,当时心脏骤停,没有脉搏和血压。心电图显示持续性室性心动过速,经两次直流电击(100J + 150J)终止。记忆和病史显示,她已经切除了宫颈鳞状细胞癌,随后接受了10个计划周期中的7个化疗周期和28个周期的放疗周期。病人随后被转移到冠状动脉病房,在那里进行心脏超声检查。右心室内发现一31 × 50 mm的均匀肿块。鉴于此,我们进行了心脏磁共振成像。这证实了右心室肿瘤肿块的存在。不幸的是,出院仅一个月后,患者就因意识丧失住进了神经内科。颅腔计算机断层扫描显示转移性脑病变。仅仅几个月后,病人就死于这种疾病。结论。我们报告一例罕见的死前诊断为右心室转移的宫颈癌患者。对这些患者的诊断在日常临床实践中是一个挑战,因为转移可以产生掩盖子宫颈癌真正词源的临床图像。
{"title":"Right ventricular metastasis of uterine cervical cancer: A case report","authors":"Milovan Stojanović, Bojan Ilić, Dragan Marinković, Sandra Šarić, Dejan Hristov, Marina Deljanin-Ilić","doi":"10.5937/afmnai40-39597","DOIUrl":"https://doi.org/10.5937/afmnai40-39597","url":null,"abstract":"Introduction. Cardiac metastasis of uterine cervical cancer diagnosed prior to mortality (antemortem) is extremely rare. Case report. A female patient 49 years old was brought to the Emergency Department of the Institute for Treatment and Rehabilitation Niška Banja in cardiac arrest, without a pulse and blood pressure. An electrocardiogram revealed sustained ventricular tachycardia, which was terminated by two DC shocks (100J + 150J). Anamnesis and medical history revealed that she had had her squamous cell carcinoma of the uterine cervix removed and had subsequently received seven out of ten planned cycles of chemotherapy and twenty-eight cycles of radiotherapy. The patient was then transferred to the Coronary Unit, where cardiac ultrasound was performed. A homogenous mass measuring 31 x 50 mm was found in the right ventricle. In view of this, cardiac magnetic resonance imaging was performed. This confirmed the presence of the tumor mass in the right ventricle. Unfortunately, only a month after being discharged from our Institute, the patient was admitted to the Clinic of Neurology due to a loss of consciousness. Computer tomography of endocranium was performed revealing metastatic brain lesions. The patient succumbed to the disease just a couple of months later. Conclusion. We presented a rare case of antemortem diagnosed right ventricle metastases in a patient with uterine cervical cancer. Setting the diagnosis in these patients is a challenge in everyday clinical practice since metastases can produce the clinical picture that masks the real etymology of uterine cervical cancer.","PeriodicalId":7132,"journal":{"name":"Acta Facultatis Medicae Naissensis","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135612319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aesthetic appearance assessment in adolescents with idiopathic scoliosis 青少年特发性脊柱侧凸的美学外观评价
IF 0.2 Q4 Medicine Pub Date : 2023-01-01 DOI: 10.5937/afmnai40-36944
V. Živković, L. Dimitrijević, H. Čolović, D. Zlatanovic, M. Spalević, N. Savić
Introduction. Aesthetic appearance is one of the major concerns in adolescent idiopathic scoliosis (AIS) patients and its improvement is one of the main treatment's goals. Poor trunk appearance is associated with reduced quality of life in adolescents with idiopathic scoliosis. Aim. To review instruments that have been created to evaluate poor trunk appearance in these children. Material and methods. PubMed database and the Consortium of Libraries of Serbia for Unified Acquisition - KoBSON were searched using the keywords "adolescent scoliosis", "aesthetic appearance", "evaluation" and "questionnaires". Results. In order to evaluate the aesthetic impairment in these patients, various instruments have been created. They can roughly be classed as instruments that assess subjective perception or objective aesthetic appearance. The first group consists primarily of self-administered quality of life questionnaires that include an aesthetic component, such as the Scoliosis Research Society 22 (SRS-22) questionnaire and the Italian Spinal Youth Quality of Life (ISYQoL) questionnaire, as well as visual scales based on patient-completed trunk drawings, such as the Walter Reed Assessment Scale, the Spinal Appearance Questionnaire, and the Trunk Appearance Perception Scale. Trunk asymmetry scales that use pictures, such as the TRACE (Trunk Aestethic Clinical Evaluation), the POTSI (Posterior Trunk Symmetry Index) and the ATSI (Anterior Trunk Symmetry Index), 2-dimensional digital photography, and surface topography can all be used to assess the aesthetic profile of subjects, allowing for objective evaluation. Conclusion. Each clinical examination should include a specific assessment of trunk asymmetry. Various instruments were developed with the goal of decreasing x-ray radiation exposure in these patients.
介绍。美观是青少年特发性脊柱侧凸(AIS)患者的主要关注点之一,其改善是主要的治疗目标之一。青少年特发性脊柱侧凸的不良躯干外观与生活质量降低有关。的目标。回顾已创建的评估这些儿童不良躯干外观的工具。材料和方法。使用关键词“青少年脊柱侧弯”、“美学外观”、“评价”和“问卷调查”对PubMed数据库和塞尔维亚统一采集图书馆联盟(KoBSON)进行了检索。结果。为了评估这些患者的审美损害,人们发明了各种各样的仪器。它们大致可以被归类为评估主观感知或客观审美外观的工具。第一组主要由自我管理的生活质量问卷组成,其中包括美学部分,如脊柱侧凸研究学会22 (SRS-22)问卷和意大利脊柱青年生活质量(ISYQoL)问卷,以及基于患者完成的躯干图的视觉量表,如沃尔特里德评估量表、脊柱外观问卷和躯干外观感知量表。使用图片的躯干不对称量表,如TRACE(躯干美学临床评价)、POTSI(后躯干对称指数)和ATSI(前躯干对称指数)、二维数码摄影和表面形貌,都可以用来评估受试者的审美特征,从而进行客观评价。结论。每次临床检查应包括对躯干不对称的具体评估。为了减少这些患者的x射线暴露,开发了各种仪器。
{"title":"Aesthetic appearance assessment in adolescents with idiopathic scoliosis","authors":"V. Živković, L. Dimitrijević, H. Čolović, D. Zlatanovic, M. Spalević, N. Savić","doi":"10.5937/afmnai40-36944","DOIUrl":"https://doi.org/10.5937/afmnai40-36944","url":null,"abstract":"Introduction. Aesthetic appearance is one of the major concerns in adolescent idiopathic scoliosis (AIS) patients and its improvement is one of the main treatment's goals. Poor trunk appearance is associated with reduced quality of life in adolescents with idiopathic scoliosis. Aim. To review instruments that have been created to evaluate poor trunk appearance in these children. Material and methods. PubMed database and the Consortium of Libraries of Serbia for Unified Acquisition - KoBSON were searched using the keywords \"adolescent scoliosis\", \"aesthetic appearance\", \"evaluation\" and \"questionnaires\". Results. In order to evaluate the aesthetic impairment in these patients, various instruments have been created. They can roughly be classed as instruments that assess subjective perception or objective aesthetic appearance. The first group consists primarily of self-administered quality of life questionnaires that include an aesthetic component, such as the Scoliosis Research Society 22 (SRS-22) questionnaire and the Italian Spinal Youth Quality of Life (ISYQoL) questionnaire, as well as visual scales based on patient-completed trunk drawings, such as the Walter Reed Assessment Scale, the Spinal Appearance Questionnaire, and the Trunk Appearance Perception Scale. Trunk asymmetry scales that use pictures, such as the TRACE (Trunk Aestethic Clinical Evaluation), the POTSI (Posterior Trunk Symmetry Index) and the ATSI (Anterior Trunk Symmetry Index), 2-dimensional digital photography, and surface topography can all be used to assess the aesthetic profile of subjects, allowing for objective evaluation. Conclusion. Each clinical examination should include a specific assessment of trunk asymmetry. Various instruments were developed with the goal of decreasing x-ray radiation exposure in these patients.","PeriodicalId":7132,"journal":{"name":"Acta Facultatis Medicae Naissensis","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71195922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can continuous glucose monitoring be used as a new tool for diagnosing white coat hyperglycaemia and possibly some other entities? 连续血糖监测能否作为诊断白大褂高血糖和其他疾病的新工具?
IF 0.2 Q4 Medicine Pub Date : 2023-01-01 DOI: 10.5937/afmnai40-37498
M. Stojanović, Milica Pešić, S. Ilić, M. Deljanin-Ilić, V. Ćirić
Introduction. Since 1999 continuous glucose monitoring (CGM) has been used to measure the amount of glucose in the interstitial fluid. CGM is crucial when it comes to developing the ambulatory glucose profile and giving information on time spent in range (TIR), percentage of time spent above and below range, as well as variability. Discussion. It was in 1992 that Campbell et al. first described white coat hyperglycaemia, who explained it as patients having elevated blood glucose levels in a clinician's office or laboratory and normal glucose levels obtained by self-monitoring. Prior to the introduction of CGM, white coat hyperglycaemia was described as the discrepancy in the levels of office glucose and self-monitoring blood glucose (SMBG). Nowadays, it may be said that a patient has white coat hyperglycaemia when they have elevated office levels and normal SMBG levels or TIR above 70% on CGM. Recognising white coat hyperglycaemia is of crucial importance for treatment as its intensification based on office glycaemia alone can lead to episodes of hypoglycaemia and a potentially lethal outcome. Should comparison be made with arterial hypertension and ambulatory blood pressure monitoring (ABPM), CGM may provide several other options: 1) masked hyperglycaemia; 2) isolated nocturnal hyperglycaemia. Conclusion. It seems logical that CGM can be used for diagnosing white coat hyperglycaemia and possibly some (new) entities. Nonetheless, the clinical significance of all these entities can only be discussed after conducting adequately designed randomised clinical trials, which we would strongly encourage.
介绍。自1999年以来,连续血糖监测(CGM)已被用于测量间质液中的葡萄糖量。CGM在制定动态血糖谱和提供在范围内花费的时间(TIR)、在范围以上和以下花费的时间百分比以及可变性方面的信息时至关重要。讨论。1992年,Campbell等人首次对白大褂高血糖进行了描述,他们将其解释为患者在临床诊室或实验室中血糖水平升高,而通过自我监测获得的血糖水平正常。在引入CGM之前,白大褂高血糖被描述为办公室血糖和自我监测血糖(SMBG)水平的差异。如今,当办公室水平升高而SMBG水平正常或CGM的TIR高于70%时,可以说患者患有白大褂高血糖。识别白大褂高血糖对治疗至关重要,因为仅基于办公室血糖的白大褂高血糖加剧可导致低血糖发作和潜在的致命结果。如果与动脉高血压和动态血压监测(ABPM)进行比较,CGM可能提供其他几种选择:1)隐蔽性高血糖;2)孤立性夜间高血糖。结论。CGM可用于诊断白大褂高血糖和可能的一些(新)实体似乎是合乎逻辑的。尽管如此,所有这些实体的临床意义只有在进行充分设计的随机临床试验后才能讨论,我们强烈鼓励这样做。
{"title":"Can continuous glucose monitoring be used as a new tool for diagnosing white coat hyperglycaemia and possibly some other entities?","authors":"M. Stojanović, Milica Pešić, S. Ilić, M. Deljanin-Ilić, V. Ćirić","doi":"10.5937/afmnai40-37498","DOIUrl":"https://doi.org/10.5937/afmnai40-37498","url":null,"abstract":"Introduction. Since 1999 continuous glucose monitoring (CGM) has been used to measure the amount of glucose in the interstitial fluid. CGM is crucial when it comes to developing the ambulatory glucose profile and giving information on time spent in range (TIR), percentage of time spent above and below range, as well as variability. Discussion. It was in 1992 that Campbell et al. first described white coat hyperglycaemia, who explained it as patients having elevated blood glucose levels in a clinician's office or laboratory and normal glucose levels obtained by self-monitoring. Prior to the introduction of CGM, white coat hyperglycaemia was described as the discrepancy in the levels of office glucose and self-monitoring blood glucose (SMBG). Nowadays, it may be said that a patient has white coat hyperglycaemia when they have elevated office levels and normal SMBG levels or TIR above 70% on CGM. Recognising white coat hyperglycaemia is of crucial importance for treatment as its intensification based on office glycaemia alone can lead to episodes of hypoglycaemia and a potentially lethal outcome. Should comparison be made with arterial hypertension and ambulatory blood pressure monitoring (ABPM), CGM may provide several other options: 1) masked hyperglycaemia; 2) isolated nocturnal hyperglycaemia. Conclusion. It seems logical that CGM can be used for diagnosing white coat hyperglycaemia and possibly some (new) entities. Nonetheless, the clinical significance of all these entities can only be discussed after conducting adequately designed randomised clinical trials, which we would strongly encourage.","PeriodicalId":7132,"journal":{"name":"Acta Facultatis Medicae Naissensis","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71195954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Moxifloxacin-induced mental status change 莫西沙星诱导的精神状态改变
IF 0.2 Q4 Medicine Pub Date : 2023-01-01 DOI: 10.5937/afmnai40-36485
S. Güler, D. Kocaşaban
Introduction: Moxifloxacin is an antibiotic used orally or parenterally in the emergency department (ED) for the treatment of various infections, especially acute exacerbation of chronic bronchitis and community-acquired pneumonia. The side effects of the drug are mainly on the gastrointestinal system, while the central nervous system side effects are rare. Case report: Herein, we present an elderly patient who had altered mental status associated with the use of moxifloxacin. Upon discontinuation of the drug, the patient quickly returned to baseline neurologic status. In the evaluation of altered mental status in elderly patients in the ED, much of the effort should be spent primarily on ruling out more complex diagnoses. However, this approach requires more invasive and advanced testing. Conclusion: Considering drug side effects among these more complicated diagnoses may increase noninvasive and radiation-free options for the patient and physician.
莫西沙星是一种抗生素,在急诊科(ED)用于治疗各种感染,特别是慢性支气管炎和社区获得性肺炎的急性加重。该药的副作用主要在胃肠道系统,而中枢神经系统的副作用很少。病例报告:在这里,我们提出了一个老年患者,他的精神状态改变与使用莫西沙星有关。停药后,患者迅速恢复到基线神经状态。在评估急诊科老年患者的精神状态改变时,大部分的努力应该主要用于排除更复杂的诊断。然而,这种方法需要更多的侵入性和高级测试。结论:在这些更复杂的诊断中考虑药物副作用可能会增加患者和医生的无创和无辐射选择。
{"title":"Moxifloxacin-induced mental status change","authors":"S. Güler, D. Kocaşaban","doi":"10.5937/afmnai40-36485","DOIUrl":"https://doi.org/10.5937/afmnai40-36485","url":null,"abstract":"Introduction: Moxifloxacin is an antibiotic used orally or parenterally in the emergency department (ED) for the treatment of various infections, especially acute exacerbation of chronic bronchitis and community-acquired pneumonia. The side effects of the drug are mainly on the gastrointestinal system, while the central nervous system side effects are rare. Case report: Herein, we present an elderly patient who had altered mental status associated with the use of moxifloxacin. Upon discontinuation of the drug, the patient quickly returned to baseline neurologic status. In the evaluation of altered mental status in elderly patients in the ED, much of the effort should be spent primarily on ruling out more complex diagnoses. However, this approach requires more invasive and advanced testing. Conclusion: Considering drug side effects among these more complicated diagnoses may increase noninvasive and radiation-free options for the patient and physician.","PeriodicalId":7132,"journal":{"name":"Acta Facultatis Medicae Naissensis","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71196123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implications of anesthetic techniques on cardiocirculatory stability in laparoscopic cholecystectomy 腹腔镜胆囊切除术中麻醉技术对心肺循环稳定性的影响
IF 0.2 Q4 Medicine Pub Date : 2023-01-01 DOI: 10.5937/afmnai40-38044
B. Stosic, M. Stosic, Jelena D Zivadinovic, I. Veselinović
Background and Aim: The aim of the present study was to compare the effect of volatile induction and maintenance of anesthesia (VIMA) and target controlled infusion (TCI) on cardiovascular stability in New York Heart Association (NYHA) grade II patients who underwent laparoscopic cholecystectomy. Patients and methods: In the present study, 90 patients were randomized into two groups depending on whether they received VIMA or TCI. Heart rate, systolic, diastolic and mean arterial pressure were monitored continuously and recorded in five time intervals. Results: Statistical analysis showed that VIMA with sevoflurane provides better cardiocirculatory stability (less than 10% deviation from basal values for each measured parameter) than TCI group (p < 0.01). Conclusion: Volatile induction and maintenance of anesthesia with sevoflurane provides better hemodynamic stability for NYHA II patients with concomitant cardiovascular diseases compared to TCI.
背景与目的:本研究的目的是比较挥发性诱导和维持麻醉(VIMA)和靶控输注(TCI)对纽约心脏协会(NYHA)二级腹腔镜胆囊切除术患者心血管稳定性的影响。患者和方法:在本研究中,90例患者根据是否接受VIMA或TCI随机分为两组。连续监测心率、收缩压、舒张压和平均动脉压,并按5个时间间隔记录。结果:经统计学分析,七氟醚VIMA组比TCI组具有更好的心脏循环稳定性(各项测量参数与基础值偏差小于10%)(p < 0.01)。结论:与TCI相比,七氟醚挥发性诱导和维持麻醉可为合并心血管疾病的NYHA II患者提供更好的血流动力学稳定性。
{"title":"Implications of anesthetic techniques on cardiocirculatory stability in laparoscopic cholecystectomy","authors":"B. Stosic, M. Stosic, Jelena D Zivadinovic, I. Veselinović","doi":"10.5937/afmnai40-38044","DOIUrl":"https://doi.org/10.5937/afmnai40-38044","url":null,"abstract":"Background and Aim: The aim of the present study was to compare the effect of volatile induction and maintenance of anesthesia (VIMA) and target controlled infusion (TCI) on cardiovascular stability in New York Heart Association (NYHA) grade II patients who underwent laparoscopic cholecystectomy. Patients and methods: In the present study, 90 patients were randomized into two groups depending on whether they received VIMA or TCI. Heart rate, systolic, diastolic and mean arterial pressure were monitored continuously and recorded in five time intervals. Results: Statistical analysis showed that VIMA with sevoflurane provides better cardiocirculatory stability (less than 10% deviation from basal values for each measured parameter) than TCI group (p < 0.01). Conclusion: Volatile induction and maintenance of anesthesia with sevoflurane provides better hemodynamic stability for NYHA II patients with concomitant cardiovascular diseases compared to TCI.","PeriodicalId":7132,"journal":{"name":"Acta Facultatis Medicae Naissensis","volume":null,"pages":null},"PeriodicalIF":0.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71196143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Facultatis Medicae Naissensis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1